| RDEA 594 |
雷西那德 |
878672-00-5 |
| Olaparib |
奥拉帕尼 |
763113-22-0 |
| Vipadenant |
3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-D]嘧啶-5-胺 |
442908-10-3 |
| Urea, N-[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)Methyl]-2-Methyl-1-piperazinyl]-2-oxoethoxy]phenyl]- |
(R)-1-(5-氯-2-(2-(4-(4-氟苄基)-2-甲基哌嗪-1-基)-2-氧代乙氧基)苯基)脲 |
217645-70-0 |
| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 |
1429881-91-3 |
| EW-7197 |
EW-7197 |
1352608-82-2 |
| GSK591 |
GSK591 (EPZ-015866) |
1616391-87-7 |
| AMG-3969 |
AMG-3969 |
1361224-53-4 |
| CEP 33779 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1257704-57-6 |
| TAK-632 |
TAK-632 |
1228591-30-7 |
| GS9620 |
GS9620 |
1228585-88-3 |
| MKC3946 |
1093119-54-0 |
1093119-54-0 |
| MK-4827 (tosylate) |
(3S)-3-[4-[7-(氨基羰基)-2H-吲唑-2-基]苯基]哌啶对甲苯磺酸盐 |
1038915-73-9 |
| LY 294002 HYDROCHLORIDE |
LY294002/PI3K抑制剂 |
154447-36-6 |
| SH-4-54 |
SH-4-54 |
1456632-40-8 |
